Technology News and Research

RSS

European Dynamic Annuloplasty Activation study completes patient enrollment

MiCardia (MiCardia Corporation, Irvine, California) today announced the completion of enrollment in its European “DYANA” (Dynamic Annuloplasty Activation) study, designed to support submission for CE mark of the firm’s Dynaplasty technology in Europe.

9 Sep 2009

Humana implements Application Security's DbProtect to manage critical information

Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.

9 Sep 2009

Nexus launches Healthcare Practice

Nexus, a leading provider of advanced technology and network integration, announced the launch of a focused Healthcare Practice. Healthcare is one of the fastest growing industries today and currently generates a large percentage of Nexus' revenue.

9 Sep 2009

Stocks of Medizone begin trading on the OTC Bulletin Board

Developer of ground-breaking ozone-based hospital sterilization technology -- AscepticSure(TM), Medizone announced today that its common stock has begun trading on the OTC Bulletin Board (OTC Bulletin Board: MZEI). The company's common stock was previously quoted on the Pink Sheets.

9 Sep 2009

Space-age technology to combat counterfeit pharmaceuticals

University of Leicester researchers have combined crime research and space-age technology in ways that could lead to the quick detection of counterfeit pharmaceuticals in a black market currently worth an estimated $40billion per year.

9 Sep 2009

New procedure for transapical valve replacement minimizes trauma and blood loss

Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment.

9 Sep 2009

NIH awards Vaxart $2.8M grant to develop an orally-delivered H5N1 Avian influenza vaccine

Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has been awarded a $2.8 million phase II Small Business Innovation Research grant from the National Institute of Allergy and Infectious Disease (National Institutes of Health) to support development of its first product, an orally-delivered vaccine for H5N1 Avian influenza.

9 Sep 2009

Can-Fite's Phase II clinical study of CF101 provides positive results

Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives.

9 Sep 2009

Online destination resource for diabetics

Bayer Diabetes Care is continuing to simplify life for people with diabetes with the launch of simplewins.com, an online destination designed to inspire people with diabetes and help them meet the day-to-day challenges of living with and managing the disease.

9 Sep 2009

FDA approves Cochlear's Nucleus 5 System

Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.

9 Sep 2009

Covidien acquires Power Medical Interventions

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.

9 Sep 2009

AMS adds a 3.5 cm Occlusive Cuff to its product line

American Medical Systems, Inc. (AMS), a trusted provider of medical solutions for restoring men’s and women’s pelvic health, announced today that it has expanded its AMS 800 male artificial urinary sphincter product line with the addition of a 3.5 cm Occlusive Cuff to restore urinary continence to a wider range of male patients.

9 Sep 2009

Biomagnetics Diagnostics deploys IOBS testing technology

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced its entry into the Integrated Optical Biosensor System (IOBS) market. IOBS are a relatively new classification of pathogen detection equipment which use advanced fiber optic-based technology to detect a wide variety of human and animal pathogens.

9 Sep 2009

Cell Biosciences acquires Alpha Innotech for $17.9 million

Cell Biosciences, Inc. and Alpha Innotech Corp. today announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per share, or approximately $17.9 million in cash.

9 Sep 2009

New procedure used for breast cancer surgery

Breast cancer surgeons and radiation oncologists at St. Joseph Hospital in Orange performed a new procedure combining removal of a patient’s breast tumor with the power of electron beam radiation in the operating room.

8 Sep 2009

Scientists use advanced technology to find about composite structure of skin

Leeds scientists are using the most sophisticated techniques to tackle a question almost as old as mankind itself - what makes skin feel good, and why?

8 Sep 2009

PPJ Enterprise purchases medical billing service

PPJ Enterprise (PPJ) (PINKSHEETS: PPJE), a leader in proprietary automated healthcare multi-specialty provider reimbursement cycle technology and EHR development/information management digital system software for health care providers. PPJ is generating momentum for their strong comeback. The Company's short term strategic goal is to invest into a business that can sustain its everyday operational costs. So PPJ is developing alliances and making acquisitions/mergers in the medical billing service industry to eventually regain their position in the market.

8 Sep 2009

Visual Management Systems signs a dealer agreement with High Tech Innovations

Visual Management Systems, Inc. (OTCBB: VMSY), a leading developer, manufacturer and provider of video surveillance technologies, is pleased to announce that it has entered into a dealer agreement with High Tech Innovations, a leader in technology infrastructure for the healthcare industry.

8 Sep 2009

MyMedicalRecords PHR offers medical reimbursement for H1N1 affected susbcribers

MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that it has launched a new subscriber Program to reimburse up to $5,000 for remaining medical insurance deductibles, or out-of-pocket medical expenses up to $5,000, for a MyMedicalRecords PHR subscriber family member who has a confirmed case of the H1N1 (Swine Flu) virus.

8 Sep 2009

New iso-active foaming gel delivers active ingredients to hard-to-reach areas of the mouth

The makers of Aquafresh(R) and Sensodyne(R) introduce a breakthrough technology in toothpaste - new iso-active(R) Foaming Gel. Iso-active has a revolutionary delivery system that disperses active ingredients quickly, penetrating those hard-to-reach areas of the mouth.

8 Sep 2009